CEO SUMMARY: Since its big public debut in late 2013, Theranos has been the subject of keen interest and much skepticism among pathologists and clinical laboratory professionals. Theranos is expanding its presence in Phoenix, Arizona. However, as it does, it looks more like a conventional clinical laboratory—with all the associated costs—than a disruptive lab testing […]
Theranos Pursues Different Business Plan in Arizona
Company is building CLIA lab in Scottsdale, now has sales reps canvassing docs in the area
- By Robert Michel
- > From the Volume XXI No. 14 - October 13, 2014 Issue
- Tags: cap, clia, clia lab, clinical lab, clinical lab test, clinical lab testing, clinical laboratories, Clinical Laboratory, clinical laboratory scientist, clinical laboratory scientists, clinical laboratory test, clinical testing, dark report, Diagnostic technology, disruptive innovation, ehr, ehr systems, lab executive, lab industry, lab manager, lab managers, lab operation, lab operations, lab sale, lab sales, lab test, lab test prices, lab testing, lab testing services, lab tests, laboratories, laboratory company, laboratory information, laboratory information system, laboratory scientists, laboratory test, medical lab, Medicare, medicare lab, Medicare Part B, pathologists, the dark report, Theranos
